Mild cognitive impairment: vizsgálatok itt: Japán
3 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Where
- Aichi, Hiroshima, Hyōgo, Kagawa, Kanagawa, Kochi, Kyoto, Meguro-Ku, Mie, Okayama, Osaka, Tokyo, Yamagata
- Életkor
- 50 év to 90 év
- People
- 80 000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07177352 - 2. fázisTaking peopleA Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Where
- Bunkyō City, Fujisawa, Himeji, Inage, Kawasaki, Kobe, Kōtoku, Kurashiki, Nagoya, Ōbu, Suita, tabashi City, Tachikawa, Toride, Yokohama, Yufu
- Életkor
- 55 év to 85 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07589595 - 1. fázisTaking peopleA First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Where
- Bunkyō City
- Életkor
- 50 év to 85 év
- People
- 56 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06297590 · EU 2024-510604-37-00